Under Armour To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday
Telsey Advisory Group raised Under Armour, Inc.. (NASDAQ:UAA) price target from $8 to $9. Telsey Advisory Group analyst…
Karyopharm Therapeutics Q3 EPS $(0.45) Beats $(0.57) Estimate, Sales $36.15M Beat $34.56M Estimate
Karyopharm Therapeutics (NASDAQ:KPTI) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.57) by 21.05 percent. This is a 34.78 percent increase over losses of $(0.69) per
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Karyopharm And Menarini Group Announce Orphan Medicinal Product Designation From The European Commission For Selinexor For The Treatment Of Myelofibrosis
Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international
Ryder System, Harrow Health And Other Big Gainers From Tuesday
U.S. stocks closed mixed with the Dow Jones dropping around 125 points on Tuesday. Here is the list of some big stocks recording gains in the previous session.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 63 companies set new 52-week lows.
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
Here's a roundup of top developments in the biotech space over the last 24 hours: